No abstract is available for this article. mehr
Um alle Funktionen dieser Seite zu nutzen, aktivieren Sie bitte die Cookies in Ihrem Browser.
my.bionity.com
Mit einem my.bionity.com-Account haben Sie immer alles im Überblick - und können sich Ihre eigene Website und Ihren individuellen Newsletter konfigurieren.
Abstract Objective
Screening via non‐invasive prenatal testing (NIPT) involving the analysis of cell‐free DNA (cfDNA) from plasma has become readily available to screen for chromosomal and DNA aberrations through maternal blood. This report reviews a laboratory's experience with follow‐up of positive NIPT screens for microdeletions.
MethodsPatients that were screen positive by NIPT for a microdeletion involving 1p, 4p, 5p, 15q, or 22q, who underwent diagnostic studies by either CVS or amniocentesis were evaluated.
ResultsThe overall Positive Predictive Value (PPV) for 349 patients was 9.2%. When a microdeletion was confirmed, 39.3% of the cases had additional abnormal microarray findings. Unrelated abnormal microarray findings were detected in 11.8% of the patients in whom the screen positive microdeletion was not confirmed. Stretches of homozygosity in the microdeletion were frequently associated with a false positive cfDNA microdeletion result.
ConclusionsOverall, this report reveals that while cfDNA analysis will screen for microdeletions, the PPV is low; in our series it is 9.2%. Therefore, the patient should be counseled according. Confirmatory diagnostic microarray studies are imperative due to the high percentage of false positives and the frequent additional abnormalities not delineated by cfDNA analysis.
Autoren: | S. Schwartz, M. Kohan, R. Pasion, P.R. Papenhausen, L.D. Platt | |
Journal: | Prenatal Diagnosis | |
Jahrgang: | 2018 | |
Seiten: | n/a | |
DOI: | 10.1002/pd.5217 | |
Erscheinungsdatum: | 16.01.2018 |
No abstract is available for this article. mehr
Standardisation of inactivated influenza vaccines – learning from history
Abstract The single radial immunodiffusion assay has been the accepted method for determining the potency of inactivated influenza vaccines since 1978. The world‐wide adoption of this assay for vaccine standardisation was facilitated through collaborative studies that demonstrated a high ... mehr
1918 pandemic morbidity: the first wave hits the poor, the second wave hits the rich
Abstract Background Whether morbidity from the 1918‐19 influenza pandemic discriminated by socioeconomic status has remained a subject of debate for 100 years. In lack of data to study this issue recent literature have hypothesized that morbidity was “socially neutral”. Objectives ... mehr
Fachpublikationen